Chapman R - Search Results

1

Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.

Bansi D, Chapman R, Fleming K. Bansi D, et al. Among authors: chapman r. J Hepatol. 1996 May;24(5):581-6. doi: 10.1016/s0168-8278(96)80144-9. J Hepatol. 1996. PMID: 8773914

2

Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.

Bloom S, Fleming K, Chapman R. Bloom S, et al. Among authors: chapman r. Gut. 1995 Apr;36(4):604-9. doi: 10.1136/gut.36.4.604. Gut. 1995. PMID: 7537707 Free PMC article.

3

Primary biliary cirrhosis: contribution of HLA class II allele DR8.

Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, Daly AK, Idle JR, James OF, Bassendine MF. Gregory WL, et al. Among authors: chapman r. Q J Med. 1993 Jun;86(6):393-9. Q J Med. 1993. PMID: 7909617

4

Inappropriate expression of blood group antigens in hepatic allografts.

Bloom S, Fleming K, Chapman R, Neuberger J, Hubscher S. Bloom S, et al. Among authors: chapman r. Hepatology. 1994 Apr;19(4):876-81. Hepatology. 1994. PMID: 8138260

5

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.

Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E. Bansi DS, et al. Among authors: chapman r. Eur J Gastroenterol Hepatol. 1997 Jun;9(6):575-80. doi: 10.1097/00042737-199706000-00005. Eur J Gastroenterol Hepatol. 1997. PMID: 9222729 Clinical Trial.

6

Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

Yang X, Cullen SN, Li JH, Chapman RW, Jewell DP. Yang X, et al. J Hepatol. 2004 Mar;40(3):375-9. doi: 10.1016/j.jhep.2003.11.009. J Hepatol. 2004. PMID: 15123348

7

Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.

Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, Fleming KA, Banham AH, Klenerman P. Ward SM, et al. J Hepatol. 2007 Sep;47(3):316-24. doi: 10.1016/j.jhep.2007.03.023. Epub 2007 Apr 12. J Hepatol. 2007. PMID: 17475362

8

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.

Cullen SN, Rust C, Fleming K, Edwards C, Beuers U, Chapman RW. Cullen SN, et al. J Hepatol. 2008 May;48(5):792-800. doi: 10.1016/j.jhep.2007.12.023. Epub 2008 Feb 14. J Hepatol. 2008. PMID: 18314215 Clinical Trial.

9

Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis--overlapping or separate diseases?

Webster GJ, Pereira SP, Chapman RW. Webster GJ, et al. J Hepatol. 2009 Aug;51(2):398-402. doi: 10.1016/j.jhep.2009.04.010. Epub 2009 May 12. J Hepatol. 2009. PMID: 19505739 Free article. Review.

10

The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study.

Sadler R, Chapman RW, Simpson D, Soonawalla ZF, Waldegrave EL, Burden JM, Misbah SA, Ferry BL. Sadler R, et al. Among authors: chapman rw. Eur J Gastroenterol Hepatol. 2011 Feb;23(2):139-45. doi: 10.1097/meg.0b013e3283423486. Eur J Gastroenterol Hepatol. 2011. PMID: 21287719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,106 results

Search Page

Filters